Wimmer Associates 1, LLC Abb Vie Inc. Transaction History

Wimmer Associates 1, LLC

$195 Million
Q2 2024

A detailed history of Wimmer Associates 1, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Wimmer Associates 1, LLC holds 15,397 shares of ABBV stock, worth $3.01 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares

15,397

Previous 15,397 -0.0%

Holding current value

$3.01 Million

Previous $2.8 Million 5.82%

% of portfolio

1.36%

Previous 1.48%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$159.82 - $182.1 $202,172 - $230,356	-1,265 Reduced 7.59%	15,397 $2.8 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $27,520 - $30,994	200 Added 1.21%	16,662 $2.58 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $5,210 - $6,031	-39 Reduced 0.24%	16,462 $2.45 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $6,625 - $8,245	-50 Reduced 0.3%	16,501 $2.22 Million
Q1 2023 May 16, 2023	SELL	$144.61 - $166.54 $61,603 - $70,946	-426 Reduced 2.51%	16,551 $2.64 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $1,659 - $1,990	-12 Reduced 0.07%	16,977 $2.75 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $14,360 - $16,470	-107 Reduced 0.63%	16,989 $2.49 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $22,982 - $29,218	-167 Reduced 0.97%	17,096 $2.62 Million
Q1 2022 May 13, 2022	BUY	$131.98 - $163.75 $52,791 - $65,500	400 Added 2.37%	17,263 $2.8 Million
Q4 2021 Feb 16, 2022	BUY	$107.43 - $135.93 $29,328 - $37,108	273 Added 1.65%	16,863 $2.28 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $4,362 - $4,951	41 Added 0.25%	16,590 $1.79 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $3,577 - $3,985	34 Added 0.21%	16,549 $1.86 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $19,641 - $21,623	-192 Reduced 1.15%	16,515 $1.79 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $8,612 - $11,627	-107 Reduced 0.64%	16,707 $1.79 Million
Q3 2020 Dec 03, 2020	BUY	$85.91 - $100.83 $81,356 - $95,486	947 Added 5.97%	16,814 $1.47 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $79,679 - $106,623	-1,086 Reduced 6.41%	15,867 $1.47 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $88,171 - $133,678	1,367 Added 8.77%	16,953 $1.29 Million
Q4 2019 Feb 13, 2020	BUY	$72.13 - $90.25 $15,507 - $19,403	215 Added 1.4%	15,586 $1.38 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $4,723 - $5,679	-75 Reduced 0.49%	15,371 $1.16 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $7,029 - $8,985	107 Added 0.7%	15,446 $1.12 Million
Q1 2019 May 15, 2019	SELL	$77.14 - $90.79 $9,256 - $10,894	-120 Reduced 0.78%	15,339 $1.24 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $72,556 - $89,481	-932 Reduced 5.69%	15,459 $1.43 Million
Q3 2018 Nov 13, 2018	SELL	$88.91 - $98.84 $171,151 - $190,267	-1,925 Reduced 10.51%	16,391 $1.55 Million
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $5,297 - $6,267	59 Added 0.32%	18,316 $1.7 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $9,385 - $12,567	102 Added 0.56%	18,257 $1.73 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $32,958 - $36,141	-368 Reduced 1.99%	18,155 $1.76 Million
Q3 2017 Nov 14, 2017	SELL	$69.85 - $89.22 $76,625 - $97,874	-1,097 Reduced 5.59%	18,523 $1.65 Million
Q2 2017 Aug 14, 2017	BUY	N/A	19,620	19,620 $1.42 Million

Others Institutions Holding ABBV

# of Institutions

3,697

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $345B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wimmer Associates 1, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wimmer Associates 1, LLC with notifications on news.

Account

Wimmer Associates 1, LLC Abb Vie Inc. Transaction History